Profound Medical has signed an agreement to provide its MRI-guided transurethral ultrasound ablation (TULSA)-Pro prostate cancer treatment technology to imaging center operator Halo Diagnostics (Halo Dx).
Performed in the MRI suite, the TULSA-Pro procedure combines real-time MRI and robotically driven transurethral technology to destroy prostate cancer cells with ablation. Halo Dx said that TULSA-Pro is currently being offered at its Prostate Laser Center in Houston; other imaging centers are also expected to add the image-guided treatment under the multi-site deal.
